News

EMA validates Soleno’s application for Prader-Willi syndrome treatment
The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) submitted by Soleno ...
Soleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XR
Soleno Therapeutics, Inc. (NASDAQ:SLNO) has achieved a major regulatory milestone as the European Medicines Agency (EMA) ...